Presentation Information
[1-MO11-05]Astatine-211 labeled substrate-type FAP analogs as novel therapeutics targeting FAP alpha
Yoshifumi Shirakami1, Yuichiro Kadonaga1,3, Kazuko Kaneda1,2, Tadashi Watabe1, Sadahiro Naka3, Kazuhiro Ooe1,2, Masashi Murakami1,2, Hiromitsu Haba4, Atsushi Toyoshima1,2 (1.Institute for Radiation Sciences, The University of Osaka, Suita, Japan, 2.MSN Research Project, Forefront Research Center, Graduate School of Science, Osaka University, 3.Department of Pharmacy Osaka University, 4.Nishina Center for Accelerator-Based Science, RIKEN)